ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 677244 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 677244; 2) Community: the network communities that were significantly associated with the response to NSC 677244; 3) Molecule: the relationships between components within communities and NSC 677244; 4) MDR: the compounds that were significantly associated with the NSC 677244.

NSC Compound Enrichment Correlation
NSC 741296 Null 0.0209467683758286 0.21403902
NSC 748643 Mitaplatin 0.0209467683758286 0.19187501
NSC 752270 2,7-Bis-[3-(2-chloro-benzylamino)-propyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate 0.0209467683758286 0.1096966
NSC 759878 Irinotecan hydrochloride (USAN) 0.0209467683758286 0.22901619
NSC 651081 1H-Pyrrolo[1,2-a]benzimidazole-5,8-dione, 6-(acetylamino)- 2,3-dihydro-3-hydroxy-7-methyl- 0.0222343516878698 0.36318107
NSC 695267 Null 0.0222343516878698 0.021710297
NSC 727987 NSC 708783 incorporated in micelles, 0.20% (w/w) of drug 0.0222343516878698 -0.062739642
NSC 745591 Null 0.0222343516878698 -0.13746326
NSC 756134 GSK1023156A 0.0222343516878698 0.16226334
NSC 123979 Thevetin 0.0244632509325736 0.14317095
Total:35  Current:14    [First] [Prev] [Next] [Last]